Skip to main content
    P

    Processa Pharmaceuticals Inc (PCSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.72
    -0.14 (-7.53%)

    Market Cap: $5.20M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Processa Pharmaceuticals Inc (PCSA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Processa Pharmaceuticals (PCSA) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Processa Pharmaceuticals reported EPS of -$61.58. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(8/21)
    Avg Surprise
    -19.58%
    Streak
    1 Q

    Next Report

    PCSA has an expected report date of Mar 16, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, PCSA beat 8 and missed 13. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 382.86% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$61.58N/AN/AN/AN/AN/AN/AN/ANov 13, 2026
    Jun 30, 2026-$1.19N/AN/AN/AN/AN/AN/AN/AAug 14, 2026
    Sep 30, 2025-$1.75-$2.00-$2.00 - -$2.00+12.50%BeatN/A11 up, 0 downNov 6, 2025
    Jun 30, 2025-$0.25-$0.23-$0.23 - -$0.23-8.70%MissN/A10 up, 0 downAug 7, 2025
    Mar 31, 2025-$7.50-$19.25-$19.25 - -$19.25+61.04%BeatN/A10 up, 0 downMay 8, 2025
    Dec 31, 2024-$0.74-$0.92-$0.92 - -$0.92+19.57%BeatN/A10 up, 1 downMar 20, 2025
    Sep 30, 2024-$25.75-$25.00-$25.00 - -$25.00-3.00%MissN/A10 up, 0 downOct 30, 2024
    Jun 30, 2024-$25.25-$24.50-$24.50 - -$24.50-3.06%MissN/A10 up, 0 downAug 13, 2024
    Mar 31, 2024-$27.75-$29.50-$29.50 - -$29.50+5.93%BeatN/A10 up, 0 downMay 10, 2024
    Dec 31, 2023-$1.70-$1.60-$1.60 - -$1.60-6.25%MissN/A20 up, 0 downMar 29, 2024
    Sep 30, 2023-$40.00-$50.00-$50.00 - -$50.00+20.00%BeatN/A10 up, 0 downNov 13, 2023
    Jun 30, 2023-$50.00-$75.00N/A+33.33%BeatN/AN/A0 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.18-$0.28-$0.28 - -$0.28+35.71%BeatN/A10 up, 0 downMay 15, 2023
    Dec 31, 2022-$175.00-$152.50-$180.00 - -$125.00-14.75%MissN/A30 up, 0 downMar 30, 2023
    Sep 30, 2022-$185.00-$167.50-$170.00 - -$165.00-10.45%MissN/A30 up, 0 downNov 8, 2022
    Jun 30, 2022-$160.00-$95.00-$105.00 - -$95.00-68.42%MissN/A30 up, 0 downAug 12, 2022
    Mar 31, 2022-$100.00-$106.67-$120.00 - -$100.00+6.25%BeatN/A40 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.21-$0.19-$0.20 - -$0.18-10.53%MissN/A3N/AMar 30, 2022
    Sep 30, 2021-$95.00-$92.50-$105.00 - -$80.00-2.70%MissN/A30 up, 0 downNov 12, 2021
    Jun 30, 2021-$100.00-$70.00-$75.00 - -$65.00-42.86%MissN/A3N/AAug 12, 2021
    Mar 31, 2021-$70.00-$55.00-$55.00 - -$50.00-27.27%MissN/A2N/AMay 13, 2021
    Dec 31, 2020-$1.69-$0.35-$0.55 - -$0.16-382.86%MissN/A2N/AMar 25, 2021
    Sep 30, 2020-$99.75-$80.00-$80.00 - -$80.00-24.69%MissN/A1N/ANov 12, 2020
    Jun 30, 2020-$0.13N/AN/AN/AN/AN/AN/AN/AAug 5, 2020
    Mar 31, 2020-$0.16N/AN/AN/AN/AN/AN/AN/AMay 15, 2020
    Dec 31, 2019-$0.23N/AN/AN/AN/AN/AN/AN/AMar 6, 2020
    Sep 30, 2019-$0.16N/AN/AN/AN/AN/AN/AN/ANov 14, 2019
    Jun 30, 2019-$0.18N/AN/AN/AN/AN/AN/AN/AAug 14, 2019
    Mar 31, 2019-$2.72N/AN/AN/AN/AN/AN/AN/AMay 14, 2019
    Dec 31, 2018-$2.21N/AN/AN/AN/AN/AN/AN/AMar 28, 2019
    Sep 30, 2018-$3.09N/AN/AN/AN/AN/AN/AN/ANov 13, 2018
    Jun 30, 2018-$4.61N/AN/AN/AN/AN/AN/AN/AAug 14, 2018
    Mar 31, 2018-$4.35N/AN/AN/AN/AN/AN/AN/AApr 16, 2018
    Last 33 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2024 was -$79.49, after -$91.88 the year before. It was -$14.26 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2024-$79.49N/A
    Dec 31, 2023-$91.88N/A
    Dec 31, 2022-$620.00N/A
    Dec 31, 2021-$265.21N/A
    Dec 31, 2020-$101.73N/A
    Dec 31, 2019-$3.29N/A
    Dec 31, 2018-$14.26N/A

    Frequently Asked Questions About PCSA

    When is Processa Pharmaceuticals's next earnings date?

    Processa Pharmaceuticals's next earnings report is expected for Mar 16, 2027.

    How often does PCSA beat earnings estimates?

    Processa Pharmaceuticals beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +9.75%.